Literature DB >> 16645200

Quantitative DNA methylation analysis: the promise of high-throughput epigenomic diagnostic testing in human neoplastic disease.

William B Coleman1, Ashley G Rivenbark.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16645200      PMCID： PMC1867580          DOI： 10.2353/jmoldx.2006.060026

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN： 1525-1578            Impact factor:   5.568


× No keyword cloud information.
  27 in total

Review 1.  DNA methylation patterns and epigenetic memory.

Authors:  Adrian Bird
Journal:  Genes Dev       Date:  2002-01-01       Impact factor: 11.361

Review 2.  The history of cancer epigenetics.

Authors:  Andrew P Feinberg; Benjamin Tycko
Journal:  Nat Rev Cancer       Date:  2004-02       Impact factor: 60.716

3.  Genome-wide analysis reveals strong correlation between CpG islands with nearby transcription start sites of genes and their tissue specificity.

Authors:  Riu Yamashita; Yutaka Suzuki; Sumio Sugano; Kenta Nakai
Journal:  Gene       Date:  2005-03-19       Impact factor: 3.688

4.  The quantitative separation of purines, pyrimidines, and nucleosides by paper chromatography.

Authors:  R D HOTCHKISS
Journal:  J Biol Chem       Date:  1948-08       Impact factor: 5.157

5.  Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis.

Authors:  Shuji Ogino; Takako Kawasaki; Mohan Brahmandam; Mami Cantor; Gregory J Kirkner; Donna Spiegelman; G Mike Makrigiorgos; Daniel J Weisenberger; Peter W Laird; Massimo Loda; Charles S Fuchs
Journal:  J Mol Diagn       Date:  2006-05       Impact factor: 5.568

Review 6.  Diagnostic and therapeutic applications of epigenetics.

Authors:  Kazuaki Miyamoto; Toshikazu Ushijima
Journal:  Jpn J Clin Oncol       Date:  2005-06-01       Impact factor: 3.019

Review 7.  The fundamental role of epigenetic events in cancer.

Authors:  Peter A Jones; Stephen B Baylin
Journal:  Nat Rev Genet       Date:  2002-06       Impact factor: 53.242

Review 8.  Epigenomics: genome-wide study of methylation phenomena.

Authors:  K L Novik; I Nimmrich; B Genc; S Maier; C Piepenbrock; A Olek; S Beck
Journal:  Curr Issues Mol Biol       Date:  2002-10       Impact factor: 2.081

Review 9.  Epigenetics provides a new generation of oncogenes and tumour-suppressor genes.

Authors:  M Esteller
Journal:  Br J Cancer       Date:  2006-01-30       Impact factor: 7.640

Review 10.  Diagnostic application of hMLH1 methylation in hereditary non-polyposis colorectal cancer.

Authors:  Nagahide Matsubara
Journal:  Dis Markers       Date:  2004       Impact factor: 3.434
View more
  11 in total

1.  Rapid identification of promoter hypermethylation in hepatocellular carcinoma by pyrosequencing of etiologically homogeneous sample pools.

Authors:  Emelyne Dejeux; Virginie Audard; Catherine Cavard; Ivo Glynne Gut; Benoit Terris; Jörg Tost
Journal:  J Mol Diagn       Date:  2007-08-09       Impact factor: 5.568

2.  CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations.

Authors:  Shuji Ogino; Takako Kawasaki; Gregory J Kirkner; Massimo Loda; Charles S Fuchs
Journal:  J Mol Diagn       Date:  2006-11       Impact factor: 5.568

3.  DNA hypermethylation of tumors from non-small cell lung cancer (NSCLC) patients is associated with gender and histologic type.

Authors:  Stephen E Hawes; Joshua E Stern; Qinghua Feng; Linda W Wiens; Janet S Rasey; Hiep Lu; Nancy B Kiviat; Hubert Vesselle
Journal:  Lung Cancer       Date:  2009-11-28       Impact factor: 5.705

4.  The ghost in our genes: legal and ethical implications of epigenetics.

Authors:  Mark A Rothstein; Yu Cai; Gary E Marchant
Journal:  Health Matrix Clevel       Date:  2009

5.  CpG methylation analysis--current status of clinical assays and potential applications in molecular diagnostics: a report of the Association for Molecular Pathology.

Authors:  Antonia R Sepulveda; Dan Jones; Shuji Ogino; Wade Samowitz; Margaret L Gulley; Robin Edwards; Victor Levenson; Victoria M Pratt; Bin Yang; Khedoudja Nafa; Liying Yan; Patrick Vitazka
Journal:  J Mol Diagn       Date:  2009-06-18       Impact factor: 5.568

Review 6.  Serrated polyps and their alternative pathway to the colorectal cancer: a systematic review.

Authors:  Łukasz Szylberg; Marlena Janiczek; Aneta Popiel; Andrzej Marszałek
Journal:  Gastroenterol Res Pract       Date:  2015-04-07       Impact factor: 2.260

7.  LRpath analysis reveals common pathways dysregulated via DNA methylation across cancer types.

Authors:  Jung H Kim; Alla Karnovsky; Vasudeva Mahavisno; Terry Weymouth; Manjusha Pande; Dana C Dolinoy; Laura S Rozek; Maureen A Sartor
Journal:  BMC Genomics       Date:  2012-10-04       Impact factor: 3.969

8.  Promoter methylation correlates with reduced NDRG2 expression in advanced colon tumour.

Authors:  Ada Piepoli; Rosa Cotugno; Giuseppe Merla; Annamaria Gentile; Bartolomeo Augello; Michele Quitadamo; Antonio Merla; Anna Panza; Massimo Carella; Rosalia Maglietta; Annarita D'Addabbo; Nicola Ancona; Saverio Fusilli; Francesco Perri; Angelo Andriulli
Journal:  BMC Med Genomics       Date:  2009-03-03       Impact factor: 3.063

9.  Combination of serum RASSF1A methylation and AFP is a promising non-invasive biomarker for HCC patient with chronic HBV infection.

Authors:  Xueyan Dong; Hui He; Weiying Zhang; Daojun Yu; Xianjun Wang; Yueming Chen
Journal:  Diagn Pathol       Date:  2015-08-04       Impact factor: 2.644

10.  Promoter methylation of SFRP3 is frequent in hepatocellular carcinoma.

Authors:  Ya-Wen Lin; Yu-Lueng Shih; Gi-Shih Lien; Fat-Moon Suk; Chung-Bao Hsieh; Ming-De Yan
Journal:  Dis Markers       Date:  2014-01-21       Impact factor: 3.434
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.